TAM (Treatments and Medicines) app
TAM (Treatments and Medicines) app
  • Home
  • Feedback
  • About
  • Submit guidance
  • For Healthcare Professionals
  • For Patients and Carers
  • Notifications
Sign Out
  • Home
  • Feedback
  • About
  • Submit guidance
  • For Healthcare Professionals
  • For Patients and Carers
  • Notifications
  • Treatments and Medicines
  • For Healthcare Professionals
  • THERAPEUTIC GUIDELINES
  • HAEMATOLOGY

HAEMATOLOGY

  • Andexanet alfa: administration quick reference guide
  • Anticoagulant Recommendations
  • Anaemia Main Page
  • B12 deficiency testing and management
  • Folate testing and management
  • Lymphopenia Assessment
  • Major haemorrhage and emergency invasive procedures for direct novel anticoagulants
  • Macrocytic Anaemia
  • Microcytic Anaemia
  • Monoclonal Gammopathy of Uncertain Significance (MGUS): Follow up of patients in the community
  • Normocytic Anaemia
  • Possible Polycythaemia
  • Thrombocythaemia
  • Thrombophilia Screening
  • Thrombosis and Thrombocytopenia post coronavirus vaccine:
  • Management of major haemorrhage and emergency invasive procedures in patients on direct oral anticoagulants (DOACs)
Close

Guidance Notes

  • For Healthcare Professionals
    • COVID-19 (Coronavirus)
    • THERAPEUTIC GUIDELINES
      • ACUTE PAIN
      • ANAESTHETICS
      • BREAST
      • CANCER
      • CARDIOVASCULAR
      • CHRONIC PAIN
      • DEATH
      • DENTAL
      • DERMATOLOGY
      • DIABETES
      • EAR, NOSE AND OROPHARYNX (ENT)
      • EMERGENCY DEPARTMENT
      • EMERGENCY MEDICAL RETRIEVAL SERVICE (EMRS)
      • ENDOCRINE
      • EYES
      • FLU
      • FLUID AND ELECTROLYTES
      • FOOD FLUID AND NUTRITION
      • GASTRO-INTESTINAL
      • GYNAECOLOGY
      • HAEMATOLOGY
        • Andexanet alfa: administration quick reference guide
        • Anticoagulant Recommendations
        • Anaemia Main Page
        • B12 deficiency testing and management
        • Folate testing and management
        • Lymphopenia Assessment
        • Major haemorrhage and emergency invasive procedures for direct novel anticoagulants
        • Macrocytic Anaemia
        • Microcytic Anaemia
        • Monoclonal Gammopathy of Uncertain Significance (MGUS): Follow up of patients in the community
        • Normocytic Anaemia
        • Possible Polycythaemia
        • Thrombocythaemia
        • Thrombophilia Screening
        • Thrombosis and Thrombocytopenia post coronavirus vaccine:
        • Management of major haemorrhage and emergency invasive procedures in patients on direct oral anticoagulants (DOACs)
      • INFECTIONS (ANTIMICROBIAL GUIDANCE)
      • LIVER
      • LYMPHOEDEMA
      • MENTAL HEALTH
      • MIDWIFERY & OBSTETRICS
      • NEONATAL
      • NERVOUS SYSTEM
      • OCCUPATIONAL THERAPY
      • OOH: OUT OF HOURS
      • ORTHOPAEDICS
      • PAEDIATRICS
      • PALLIATIVE CARE
      • PATIENT TRANSFER
      • PUBLIC HEALTH
      • RADIOLOGY
      • RENAL DISORDERS
      • RESPIRATORY
      • RHEUMATOLOGY
      • SEXUAL HEALTH
      • STROKE
      • SURGICAL
      • UROLOGY
      • VASCULAR
    • ANTIMICROBIAL GUIDANCE
    • FORMULARIES (and the Pink One)
    • PATIENT INFORMATION
    • FURTHER CLINICAL RESOURCES

Powered by Quris